Subscribe and Save on All of Our Products!

New Treatment For Vulvodynia in 2022

Vulvodynia is a kind of severe neuropathic pain. Vulvodynia causes acute, burning, or electric shock-like agony around the vulva, labia, or vaginal entrance in women. There are many new treatment for vulvodynia. Most studies believe that nerve injury or irritation is reported in the majority of cases.

We mentioned several new treatment for vulvodynia in this article Among these include vulvar skin care, medicines (oral and/or topical), biofeedback training, physiotherapy, dietary adjustments, and psychotherapy. As adjuvant therapies, massage therapy, cognitive behavioral therapy, and acupuncture are being investigated as types of pain.

Advanced Vulvodynia Treatments

The primary goal of Vulvodynia Treatment is to control your discomfort, improve your quality of life (create a joyful sexual life and alleviate stress), and prevent adverse effects. As a result, there is no effective treatment for vulvodynia. There are many new treatment for vulvodynia, according to researchers and worldwide consensus recommendations, some of which are included below:

  • Therapy With Local Anesthetics
  • Commitment and Acceptance Therapy (ACT)
  • Vulvodynia Treatment via the Internet
  • Pelvic Floor Muscle Therapy

1. Therapy With Local Anesthetics to Treat Vulvodynia


Vulvodynia (chronic vulvar pain) affects 10% of the population and is sexually disastrous sexual health.


Doctors investigate the efficacy of local anesthetic therapy (TLA) in women suffering from severe vulvodynia.


In an outpatient clinic in Germany, 45 patients with severe chronic vulvodynia (primary and secondary vulvodynia, 0–10 numeric analogue scale (NAS) 6, median 7.9, duration 6 months, median 65.2 months) were treated with TLA in 3–12 sessions using procaine 1% as the local anesthetic. The efficacy was tested using Wilcoxon signed rank and Wilcoxon rank sum tests. A pain reduction of 4 NAS that lasts for 6 months after the procedure is considered a success.


In 36 of 45 patients, TLA successfully reduced vulvodynia (80 percent , responders). The NAS dropped from 7.9 to 2.4 percent (P.001). Even non-responders had a significant decrease in NAS (P =.03). Long-term success was seen in responders lasting 6.8–125 months (median 24.1 months). There were no adverse consequences anti inflammatory.

Clinical Translation

A potentially new treatment for a hard-to-treat chronic pain condition in women medical conditions.

Strengths and Limitations

Limitation: Monocentric observational design with no control.

Strength: the large number of patients treated after having the symptoms of vulvodynia


The high success rate of TLA in this study throws new insight on the origins of vulvodynia as a complex pain illness affecting several nerves in the pelvic floor, as well as giving early evidence of TLA’s efficacy in women with vulvodynia side effects.

2. Commitment and Acceptance Therapy (ACT) for Vulvodynia patients

Introduction to new treatment for vulvodynia

Vulvodynia is a condition that produces persistent vulval pain and has a detrimental impact on emotional and sexual well-being. Despite the fact that commitment and acceptance therapy (ACT) has been found to be useful in the treatment of chronic pain, it has not been tested in this population. The purpose of this single-case experimental design (SCED) study was to explore if an online ACT programme improves Vulvodynia patients’ treatment outcomes in physical therapy.


This study used a nonconcurrent multiple baseline SCED technique to measure ACT in women with Vulvodynia. During the baseline and treatment periods, participants self-reported daily pain severity and interference, sexual functioning and satisfaction, depression, and hypothesised process-variables. Full-length evaluations of these criteria were also done before and after therapy. In the intervention, a six-week online ACT programme was combined with a Vulvodynia-specific manual. Visual and statistical analyses were also carried out.


Seven people in women’s health, mostly with complicated Vulvodynia, completed the intervention and kept diaries, as well as providing data from the baseline and therapy phases. Based on eye examination and Tau and Tau-U values as impact sizes from daily data, all subjects showed moderate magnitude increases in two or more outcomes. Participants, on the other hand, showed a wide range of treatment effects. The depression hardly improved. Pain acceptance, dedicated activity, and perceived injustice all changed in some people.


According to the findings, online ACT may help some women with Vulvodynia reduce discomfort and improve sexual outcomes. Pain acceptance, dedicated action, and sensed injustice are all mentioned as possible transformation pathways for certain people. In general, therapeutic responses are very personalized. It is recommended that the SCED approach for ACTing for Vulvodynia be employed more often.

3. Vulvodynia Treatment via the Internet


It is an age of mobile phones/laptops and the internet is the backbone of it. Researchers have developed a new treatment for vulvodynia namely Vulvodynia Treatment via the internet. Although there is minimal data on internet-based treatment for women with vulvodynia using ACT principles, it may improve accessibility and decrease stigma associated with seeking adequate medical care.


The goal of this study was to compare the effects of an internet-based pain therapy against no intervention for women with induced vulvodynia while waiting for medical treatment.


From 2016 through 2020, a multicenter randomized controlled trial with 99 participants was conducted. Participants were randomly allocated to either normal treatment or a 6-week internet-based guided therapy based on ACT principles. Data was collected at the start, 6 weeks later, and around 10 months afterwards.


The therapy was beneficial in terms of pain acceptance and discomfort during intercourse. At both post-treatment (primary endpoint, P =.01, Cohen’s d = 1.4, 95 percent CI = 0.33, 2.4) and follow-up (P =.04), women in the intervention group reported decreased discomfort during intercourse. The absolute mean difference in pain during intercourse between groups was -2.84 (95 percent CI = -4.91, -0.78) at post-treatment, and it was -1.58 (95 percent CI = -3.17, 0.02) at follow-up, with the intervention group experiencing less pain than the controls. There were no differences in tampon test results or the impact of pain on sexual function across groups over time.

There was a significant difference between groups at all timepoints, indicating that those in the intervention group attempted fewer intercourse attempts. In comparison to the control group, women who received internet-based therapy reported greater pain acceptance and higher activity engagement after treatment.

Clinical Implications

There is evidence that internet-based treatment can be used as a supplement to clinical treatment in clinical practice.

Strengths & Limitations

The utilization of several recruitment strategies and an intervention created by clinicians with substantial experience treating patients with vulvodynia were two of the study’s strengths. The high dropout rate of the trial constituted a disadvantage.


Internet-based treatment may minimize discomfort during intercourse, and pain acceptance may improve. Because of the small sample size, decisions must be made with caution.

Pelvic Floor Muscle Therapy


Pelvic floor reconstruction is a group of surgical procedures used to treat a condition in which the muscles of the pelvic floor become weak or damaged, usually as a result of childbirth. Other factors include frequent heavy lifting, severe sickness, or surgery.


A physical therapist should check nerves, muscles, joints, and in the lower body, in addition to the pelvic floor muscles, to examine if they result in vulvar discomfort. Physical therapists who specialize in the pelvic floor now provide a far more complete approach to the treatment of persistent vulvar and pelvic discomfort.


When nonsurgical methods fail, pelvic floor reconstruction is performed to restore the normal structure and function of the female pelvic organs. Pelvic floor physical treatment is not uncommon. Initially, the pelvic floor muscles were thought to be a source of severe chronic vulvar discomfort. In early trials, surface electromyography or biofeedback were shown to be successful in treating hypertonic PFMs (pelvic floor muscles), and sexual dysfunction and vulvar discomfort symptoms were alleviated.

Treatments include:

  • Manual therapy, both internal and external (Myofascial release, contract/relax , and trigger-point pressures are some of the techniques used.)
  • Soft-tissue work
  • Joint mobilization (for example, heat/cold)
  • Pelvic floor muscle control and motor control (Relaxation is required during vaginal insertion.)
  • Biofeedback (traditional or manual)
  • Electrical stimulation may be beneficial.

Vulvodynia Pain Relief a New Treatment For Vulvodynia

Vulvodynia is a chronic pain disease of the vulva (the area surrounding your vaginal entrance) that causes pain or discomfort for three months or longer. The vulva soreness might be persistent or intermittent. Stress or irritants can both create pain. There’s no need to worry; Syren Intimate Relief Topical Treatment for Vulvodynia is here to assist!

Syren Intimate Relief is a moisturizing gel that contains essential ingredients that can assist to relieve burning and irritation while also decreasing dryness on the vaginal area. Avoid oily creams and ointments. Intimate Relief is considerably easier to apply and spreads evenly throughout your skin. Once it’s absorbed, you’ll forget you used it!

Vulvodynia’s Impact on Daily Life

Vulvodynia can be painful physically, sexually, and psychologically. Patients with vulvodynia have trouble exercising, being intimate, and engaging in other daily activities. Even long durations of sitting may induce vulvar pain in some people.
An NIH-funded research done at Rutgers Robert Wood Johnson Medical School and reported by the National Vulvodynia Association:

  • Vulvodynia causes 75% of women to feel “out of control” of their bodies.
  • Sixty percent believe their illness makes it difficult to live a happy life.

Over two-thirds (60%) of women with vulvodynia are unable to engage in sexual activity due to the discomfort. The mere prospect of vulvar pain can generate anxiety, leading many women to avoid sexual activity. Abstinence from sex has an effect on a woman’s self-image, and frequent experiences of discomfort combined with the anticipation of pain can induce muscle spasms around the vaginal region (vaginismus), making vaginal penetration more difficult.

Furthermore, according to the American college of obstetricians and gynecologists, some women with vulvodynia may have fibromyalgia, interstitial cystitis, chronic fatigue syndrome, irritable bowel syndrome, muscle issues, or temporomandibular joint disorder.

Diagnostic and treatment are more challenging owing to medical professionals’ lack of knowledge and the stigma that women associate with genital disorders. As a result, many women question why they are feeling such strong, often incapacitating vulvar discomfort, which can strain a couple’s sexual relationship.

Some women are scared to discuss their sexual difficulties with their doctors, and those who do report that their pain is usually disregarded as “all in our heads.” Communication and knowledge are required for proper diagnosis of external genitals and treatment of this condition.